- Home
- EXEL vs HSIC Comparison
EXEL vs HSIC Comparison
Compare EXEL & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- HSIC
- Stock Information
- Founded
- EXEL 1994
- HSIC 1932
- Country
- EXEL United States
- HSIC United States
- Employees
- EXEL N/A
- HSIC N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- HSIC Medical Specialities
- Sector
- EXEL Health Care
- HSIC Health Care
- Exchange
- EXEL Nasdaq
- HSIC Nasdaq
- Market Cap
- EXEL 10.4B
- HSIC 8.4B
- IPO Year
- EXEL 2000
- HSIC 1995
- Fundamental
- Price
- EXEL $40.35
- HSIC $68.50
- Analyst Decision
- EXEL Buy
- HSIC Buy
- Analyst Count
- EXEL 22
- HSIC 12
- Target Price
- EXEL $44.00
- HSIC $76.25
- AVG Volume (30 Days)
- EXEL 2.3M
- HSIC 1.4M
- Earning Date
- EXEL 10-28-2025
- HSIC 11-04-2025
- Dividend Yield
- EXEL N/A
- HSIC N/A
- EPS Growth
- EXEL 81.76
- HSIC 15.03
- EPS
- EXEL 2.08
- HSIC 3.11
- Revenue
- EXEL $2,230,005,000.00
- HSIC $12,773,000,000.00
- Revenue This Year
- EXEL $9.19
- HSIC $4.62
- Revenue Next Year
- EXEL $12.54
- HSIC $3.55
- P/E Ratio
- EXEL $19.56
- HSIC $21.76
- Revenue Growth
- EXEL 10.73
- HSIC 2.29
- 52 Week Low
- EXEL $25.17
- HSIC $60.56
- 52 Week High
- EXEL $49.62
- HSIC $82.49
- Technical
- Relative Strength Index (RSI)
- EXEL 61.73
- HSIC 49.29
- Support Level
- EXEL $38.37
- HSIC $66.98
- Resistance Level
- EXEL $40.78
- HSIC $70.69
- Average True Range (ATR)
- EXEL 1.01
- HSIC 1.74
- MACD
- EXEL 0.41
- HSIC 0.02
- Stochastic Oscillator
- EXEL 91.21
- HSIC 42.52
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.